TRIM24

Across TCGA pan-cancer cohorts, TRIM24 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of TRIM24’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where TRIM24 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TRIM24 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

LUAD, LSCC, and COAD are the cancer types where TRIM24 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRIM24 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	+0.473	<.001	9	view →
LSCC	Male	All	+0.475	<.001	8	view →
COAD	Female	III,IV	+0.471	<.001	6	view →
PDAC	Female	II,III,IV	−0.373	<.001	5	view →
OV	All	All	+0.368	.007	2	view →
CCRCC	All	II,III,IV	−0.074	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

TRIM24–LUAD

Open the LUAD breakdown →